Assessment Effect of Bopronorphin Neonates With Obstinence Syndrom
Phase 3
Recruiting
- Conditions
- eonatal Abstinence Syndrome.Neonatal withdrawal symptoms from maternal use of drugs of addiction
- Registration Number
- IRCT20181231042183N1
- Lead Sponsor
- Birjand University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Postnatal Age<7 Days
Gestational Age= 35 Weeks
Prenatal Opium Exposure
Symptomatic Patient And 3 Fingan Score =8 In 3 Hours Or 2 Fingan Score=12
No Siezure History
No Major Congenital Anomaly
No Unstablity In Blood Pressure And Hemodynamic
No Major Medical Unstability In Association Of Withdrawal Syndrome
Exclusion Criteria
Analgesic Consumption and withdrawal syndrome
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Admit Duration. Timepoint: Duration of Admit. Method of measurement: Observation of physician.;Drugs Complications. Timepoint: Admit Duration. Method of measurement: Observation of physician.;Apnea. Timepoint: Admit Duration. Method of measurement: Observation of physician.;Feeding. Timepoint: Admit Duration. Method of measurement: Observation of physician.;Blood Pressure. Timepoint: Admit Duration. Method of measurement: Mercurial Pressure-Gauge Device.
- Secondary Outcome Measures
Name Time Method